BCL2 and renal cell carcinoma: This fact can explain RCC's high resistance to conventional chemo- and radiotherapy, and the absence of Bcl-2 had a positive predictive value for the response to immunotherapy in metastatic RCC, as was disclosed in our recent study (Maruyama et al, 2006).